Home/ Stocks/ MIST

Milestone Pharmaceuticals Inc. Common Shares

MIST XNAS

$1.22 +0.04 (+3.39%) ▲ 15-min delayed

Open

$1.18

High

$1.22

Low

$1.16

Volume

987.2K

Market Cap

$146.91M

About Milestone Pharmaceuticals Inc. Common Shares

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 38 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$238.0K	$-26,066,000	$-0.20
FY 2025	N/A	$-63,058,000	$-0.75
Q3 2025	N/A	$-11,922,000	$-0.12
Q2 2025	N/A	$-12,966,000	$-0.20

Related Market News

No specific coverage for MIST yet. Check out our latest market news or earnings calendar.

Get MIST Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Milestone Pharmaceuticals Inc. Common Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.